Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Q Fever Vaccine NDBR 105 in At-Risk Personnel
NCT00584454Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Feb 2006
- Primary completion
- Jul 2009
- Countries
- 1
01
Overview
Phase 2, open-label trial of q fever vaccine in Q fever, sponsored by U.S. Army Medical Research and Development Command. Primary endpoints: Adverse Events at 28 days and Serious Adverse Events at 1 year. Started Feb 2006; status: completed.
02
Drugs
q fever vaccine
03
Conditions
Q fever
Beyond the preview
Go deeper on NCT00584454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00584454.